160 related articles for article (PubMed ID: 25024707)
1. Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment.
To U; Kim J; Chia D
Case Rep Med; 2014; 2014():362845. PubMed ID: 25024707
[TBL] [Abstract][Full Text] [Related]
2. Disseminated Bacillus Calmette-Guérin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review.
Shimizu G; Amano R; Nakamura I; Wada A; Kitagawa M; Toru S
BMC Infect Dis; 2020 Sep; 20(1):708. PubMed ID: 32993546
[TBL] [Abstract][Full Text] [Related]
3. Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder.
Elzein F; Albogami N; Saad M; El Tayeb N; Alghamdi A; Elyamany G
Clin Med Insights Case Rep; 2016; 9():71-3. PubMed ID: 27559301
[TBL] [Abstract][Full Text] [Related]
4. Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment.
Paterson DL; Patel A
Aust N Z J Surg; 1998 May; 68(5):340-4. PubMed ID: 9631906
[TBL] [Abstract][Full Text] [Related]
5. A case of disseminated
Nishimura M; Okumura M; Takemasa T; Yoshiyama T; Tanaka Y; Saotome M; Ohta K
Respir Med Case Rep; 2023; 45():101902. PubMed ID: 37538979
[TBL] [Abstract][Full Text] [Related]
6. The first case of bacillus Calmette-Guérin-induced small-vessel central nervous system vasculitis.
Parent ME; Richer M; Liang P
Clin Rheumatol; 2018 Aug; 37(8):2297-2302. PubMed ID: 29740727
[TBL] [Abstract][Full Text] [Related]
7. Left Anterior Descending Coronary Artery and Multiple Peripheral Mycotic Aneurysms Due to Mycobacterium Bovis Following Intravesical Bacillus Calmette-Guerin Therapy: A Case Report.
Duvnjak P; Laguna M
J Radiol Case Rep; 2016 Aug; 10(8):12-27. PubMed ID: 27761190
[TBL] [Abstract][Full Text] [Related]
8. Systemic Bacillus Calmette-Guérin (BCG) Infection and Accompanying Warm Autoimmune Haemolytic Anaemia Following Intravesical BCG Immunotherapy.
Güven AT; Demiroğlu YZ; Koçer NE
Eur J Case Rep Intern Med; 2023; 10(9):004009. PubMed ID: 37680784
[TBL] [Abstract][Full Text] [Related]
9. [A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma].
Kudo T; Iwasa N; Maeda S; Mitarai S
Kansenshogaku Zasshi; 2016 Nov; 90(6):809-13. PubMed ID: 30277373
[TBL] [Abstract][Full Text] [Related]
10. A CASE OF INTRAVESICAL BACILLUS CALMETTE-GUERIN-RELATED ENDOPHTHALMITIS AND RETINITIS CONFIRMED WITH RETINAL BIOPSY.
Huggins A; Adam M; Ehmann D; Eagle RC; Malloy B; Garg SJ
Retin Cases Brief Rep; 2019; 13(4):333-336. PubMed ID: 28644177
[TBL] [Abstract][Full Text] [Related]
11. A Case of Epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma in a patient with latent tuberculosis infection.
Colomba C; Di Carlo P; Guadagnino G; Siracusa L; Trizzino M; Gioè C; Cascio A
Infect Agent Cancer; 2016; 11():25. PubMed ID: 27257433
[TBL] [Abstract][Full Text] [Related]
12. Mycobacteria Bovis osteomyelitis following intravesical BCG for bladder cancer.
Seegobin K; Maharaj S; Baldeo C; Isache C; Gharia B; Zuberi L
IDCases; 2017; 10():75-78. PubMed ID: 29034173
[TBL] [Abstract][Full Text] [Related]
13. Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma.
Nadasy KA; Patel RS; Emmett M; Murillo RA; Tribble MA; Black RD; Sutker WL
South Med J; 2008 Jan; 101(1):91-5. PubMed ID: 18176300
[TBL] [Abstract][Full Text] [Related]
14. Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer.
Lukacs S; Tschobotko B; Szabo NA; Symes A
Case Rep Urol; 2013; 2013():821526. PubMed ID: 23844314
[TBL] [Abstract][Full Text] [Related]
15. Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy.
Klebanov N; Raghavan A
Cureus; 2018 May; 10(5):e2703. PubMed ID: 30062077
[TBL] [Abstract][Full Text] [Related]
16. Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancer.
Rawls WH; Lamm DL; Lowe BA; Crawford ED; Sarosdy MF; Montie JE; Grossman HB; Scardino PT
J Urol; 1990 Dec; 144(6):1328-30. PubMed ID: 2231917
[TBL] [Abstract][Full Text] [Related]
17. Microscopic detection of bacillus Calmette-Guérin mycobacteria in bladder biopsy using fluorescence
Loukil A; Baron SA; Argemi X; Maubon T; Eldin C
New Microbes New Infect; 2021 Jan; 39():100826. PubMed ID: 33425363
[TBL] [Abstract][Full Text] [Related]
18. [Granulomatous hepatitis revealing a Mycobacterium bovis widespread infection following intravesical BCG therapy].
Raffray L; Rivière P; Bonnet H; Duffau P; Longy-Boursier M
Rev Med Interne; 2015 Sep; 36(9):626-30. PubMed ID: 25467298
[TBL] [Abstract][Full Text] [Related]
19. Tuberculous spondylitis following intravesical bcg-instillation in the treatment of transitional cell carcinoma: Case report and systematic review.
Broekx S; Buelens E
Clin Neurol Neurosurg; 2020 Jul; 194():105944. PubMed ID: 32480296
[TBL] [Abstract][Full Text] [Related]
20. Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
Pérez-Jacoiste Asín MA; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Tejido Á; San Juan R; Arrebola-Pajares A; Lizasoain M; Prieto S; Aguado JM
Medicine (Baltimore); 2014 Oct; 93(17):236-254. PubMed ID: 25398060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
